Scarica l'app Stockscreener
6.60
5.94%
0.37
Precedente Chiudi:
$6.23
Aprire:
$6.32
Volume 24 ore:
202.30K
Relative Volume:
1.12
Capitalizzazione di mercato:
$239.53M
Reddito:
$8.98M
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-4.9254
EPS:
-1.34
Flusso di cassa netto:
$-24.83M
1 W Prestazione:
+1.69%
1M Prestazione:
-21.24%
6M Prestazione:
+21.10%
1 anno Prestazione:
+4.93%
Intervallo 1D:
$6.23
$6.78
Intervallo di 1 settimana:
$6.00
$6.82
Portata 52W:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Nome
Profound Medical Corp
Settore
Industria
Telefono
647-476-1350
Indirizzo
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.60 | 226.11M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | Lake Street | Buy |
| 2024-07-16 | Aggiornamento | Stifel | Hold → Buy |
| 2023-11-28 | Iniziato | Stifel | Hold |
| 2023-08-04 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Profound Medical Corp Borsa (PROF) Ultime notizie
What margin trends mean for Profound Medical Corp. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
(PRN) Strategic Investment Guide (PRN:CA) - Stock Traders Daily
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow - marketscreener.com
Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27% - simplywall.st
Profound Medical Schedules Q4 and 2025 Results Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow - marketscreener.com
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease - Bitget
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion - TipRanks
Profound Medical Honored with INOVAIT’s 2025-2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - The Manila Times
Profound Medical Corp Receives 2025-2026 Mount Logan Award - TradingView
New prostate treatment earns Canadian tech its Mount Logan prize - Stock Titan
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
Aug Sectors: Is Profound Medical Corp in a bullish channelWatch List & Consistent Income Trade Ideas - baoquankhu1.vn
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Profound Medical Corp.'s (TSE:PRN) market cap dropped CA$42m last week; individual investors who hold 56% were hit as were institutions - simplywall.st
Profound Medical (PROF) Celebrates Milestone in Poland with 500t - GuruFocus
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health - Investing News Network
Profound Medical Marks 500th Sonalleve Procedure Milestone - TipRanks
Profound Medical Corp Celebrates 500th Sonalleve® Procedure at PRO FAMILIA - TradingView
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health - The Manila Times
500 incision-free uterine treatments completed at Polish hospital - Stock Titan
Death Cross: What hedge funds are buying Profound Medical CorpBull Run & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Outlook: Is LBRDK in a consolidation phaseWeekly Stock Summary & Long-Term Investment Growth Plans - baoquankhu1.vn
Analyzing Profound Medical (NASDAQ:PROF) & Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years - Yahoo! Finance Canada
Profound Medical (NASDAQ:PROF) Shares Down 1.3%Should You Sell? - MarketBeat
Profound Medical to Engage Investors at February Life Sciences Conferences - TipRanks
Profound Medical Corp Announces Upcoming Investor Events - TradingView
Profound Medical Announces Upcoming Investor Events - The Manila Times
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Johns Hopkins Medicine Initiates Use of Profound Medical’s TULSA-PRO System - Medical Product Outsourcing
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Profound Medical raises US$6.45 million in Canadian private placement - MSN
Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins - MSN
(PRN) Daily Stock Insights (PRN:CA) - Stock Traders Daily
Investors in Profound Medical (TSE:PRN) have unfortunately lost 67% over the last five years - Yahoo Finance
Profound Medical upsizes private placement to raise US$6.45 million - MSN
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hosp - GuruFocus
Long Term Trading Analysis for (PRN) (PRN:CA) - Stock Traders Daily
Profound Medical Expands TULSA-PRO Use at Mount Sinai - TipRanks
AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan
Profound Medical (TSE:PRN) Hits New 1-Year HighTime to Buy? - MarketBeat
Profound Medical Exceeds 2025 TULSA-PRO Installation Target and Grows Sales Pipeline - The Globe and Mail
Objective long/short (PRN) Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp Surpasses 2025 TULSA-PRO® Installation Goal - TradingView — Track All Markets
Profound Surpasses 2025 TULSA-PRO Installed Base Goal - 富途资讯
Profound Medical (PROF) Surpasses Installation Goal with TULSA-P - GuruFocus
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal - Investing News Network
How Profound Medical Corp. stock performs during Fed tightening cyclesJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Will Profound Medical Corp. stock reach all time highs in 2025Portfolio Gains Report & Low Risk High Win Rate Picks - Улправда
Profound Medical Corp Azioni (PROF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Profound Medical Corp Azioni (PROF) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):